Logo image of ARX

ACCELERANT HOLDINGS-CL A (ARX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ARX - KYG008941083 - Common Stock

15.67 USD
-0.06 (-0.38%)
Last: 12/12/2025, 8:14:30 PM
15.67 USD
0 (0%)
After Hours: 12/12/2025, 8:14:30 PM
Fundamental Rating

3

ARX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 147 industry peers in the Insurance industry. ARX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ARX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ARX was profitable.
ARX had a positive operating cash flow in the past year.
ARX Yearly Net Income VS EBIT VS OCF VS FCFARX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

ARX has a worse Return On Assets (0.57%) than 72.79% of its industry peers.
ARX has a Return On Equity (9.43%) which is comparable to the rest of the industry.
ARX's Return On Invested Capital of 1.01% is on the low side compared to the rest of the industry. ARX is outperformed by 63.27% of its industry peers.
Industry RankSector Rank
ROA 0.57%
ROE 9.43%
ROIC 1.01%
ROA(3y)-1.68%
ROA(5y)N/A
ROE(3y)-11.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARX Yearly ROA, ROE, ROICARX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -10 -20

1.3 Margins

ARX's Profit Margin of 4.34% is on the low side compared to the rest of the industry. ARX is outperformed by 72.11% of its industry peers.
With a Operating Margin value of 10.40%, ARX is not doing good in the industry: 61.22% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 10.4%
PM (TTM) 4.34%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARX Yearly Profit, Operating, Gross MarginsARX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -10 -20 -30 -40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARX is destroying value.
Compared to 1 year ago, ARX has about the same amount of shares outstanding.
ARX has a better debt/assets ratio than last year.
ARX Yearly Shares OutstandingARX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
ARX Yearly Total Debt VS Total AssetsARX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B

2.2 Solvency

ARX has an Altman-Z score of 0.41. This is a bad value and indicates that ARX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.41, ARX is in the better half of the industry, outperforming 68.71% of the companies in the same industry.
The Debt to FCF ratio of ARX is 0.16, which is an excellent value as it means it would take ARX, only 0.16 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ARX (0.16) is better than 92.52% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that ARX is not too dependend on debt financing.
ARX has a Debt to Equity ratio (0.28) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 0.16
Altman-Z 0.41
ROIC/WACC0.12
WACC8.75%
ARX Yearly LT Debt VS Equity VS FCFARX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.12 indicates that ARX may have some problems paying its short term obligations.
ARX's Current ratio of 0.12 is fine compared to the rest of the industry. ARX outperforms 63.95% of its industry peers.
ARX has a Quick Ratio of 0.12. This is a bad value and indicates that ARX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.12, ARX is doing good in the industry, outperforming 63.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
ARX Yearly Current Assets VS Current LiabilitesARX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 155.73% over the past year.
ARX shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.63%.
EPS 1Y (TTM)155.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%206.75%
Revenue 1Y (TTM)78.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%68.92%

3.2 Future

Based on estimates for the next years, ARX will show a very strong growth in Earnings Per Share. The EPS will grow by 63.39% on average per year.
ARX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.04% yearly.
EPS Next Y490.07%
EPS Next 2Y130.13%
EPS Next 3Y89.58%
EPS Next 5Y63.39%
Revenue Next Year57.65%
Revenue Next 2Y34.64%
Revenue Next 3Y28.04%
Revenue Next 5YN/A

3.3 Evolution

ARX Yearly Revenue VS EstimatesARX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ARX Yearly EPS VS EstimatesARX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

ARX is valuated quite expensively with a Price/Earnings ratio of 78.35.
83.67% of the companies in the same industry are cheaper than ARX, based on the Price/Earnings ratio.
ARX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.54.
Based on the Price/Forward Earnings ratio of 23.94, the valuation of ARX can be described as rather expensive.
76.19% of the companies in the same industry are cheaper than ARX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.78. ARX is around the same levels.
Industry RankSector Rank
PE 78.35
Fwd PE 23.94
ARX Price Earnings VS Forward Price EarningsARX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

ARX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ARX is more expensive than 64.63% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARX indicates a somewhat cheap valuation: ARX is cheaper than 74.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.4
EV/EBITDA 16.79
ARX Per share dataARX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ARX's earnings are expected to grow with 89.58% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y130.13%
EPS Next 3Y89.58%

0

5. Dividend

5.1 Amount

No dividends for ARX!.
Industry RankSector Rank
Dividend Yield N/A

ACCELERANT HOLDINGS-CL A

NYSE:ARX (12/12/2025, 8:14:30 PM)

After market: 15.67 0 (0%)

15.67

-0.06 (-0.38%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)N/A N/A
Inst Owners6.26%
Inst Owner Change0%
Ins Owners24.59%
Ins Owner Change99.81%
Market Cap3.48B
Revenue(TTM)979.50M
Net Income(TTM)42.50M
Analysts77.14
Price Target21.08 (34.52%)
Short Float %3.11%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.66%
PT rev (3m)-29.34%
EPS NQ rev (1m)-1.36%
EPS NQ rev (3m)15%
EPS NY rev (1m)17.65%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.1%
Revenue NY rev (1m)2.21%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 78.35
Fwd PE 23.94
P/S 3.55
P/FCF 4.4
P/OCF 4.2
P/B 7.71
P/tB 14.64
EV/EBITDA 16.79
EPS(TTM)0.2
EY1.28%
EPS(NY)0.65
Fwd EY4.18%
FCF(TTM)3.56
FCFY22.71%
OCF(TTM)3.73
OCFY23.79%
SpS4.42
BVpS2.03
TBVpS1.07
PEG (NY)0.16
PEG (5Y)N/A
Graham Number3.02
Profitability
Industry RankSector Rank
ROA 0.57%
ROE 9.43%
ROCE 1.41%
ROIC 1.01%
ROICexc 1.26%
ROICexgc 4.43%
OM 10.4%
PM (TTM) 4.34%
GM N/A
FCFM 80.58%
ROA(3y)-1.68%
ROA(5y)N/A
ROE(3y)-11.64%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 0.16
Debt/EBITDA 0.99
Cap/Depr 141.73%
Cap/Sales 3.85%
Interest Coverage 9.52
Cash Conversion 643.58%
Profit Quality 1857.18%
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 0.41
F-ScoreN/A
WACC8.75%
ROIC/WACC0.12
Cap/Depr(3y)271.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)155.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%206.75%
EPS Next Y490.07%
EPS Next 2Y130.13%
EPS Next 3Y89.58%
EPS Next 5Y63.39%
Revenue 1Y (TTM)78.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%68.92%
Revenue Next Year57.65%
Revenue Next 2Y34.64%
Revenue Next 3Y28.04%
Revenue Next 5YN/A
EBIT growth 1Y245.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year652.16%
EBIT Next 3Y116.99%
EBIT Next 5YN/A
FCF growth 1Y191.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y170.93%
OCF growth 3YN/A
OCF growth 5YN/A

ACCELERANT HOLDINGS-CL A / ARX FAQ

What is the ChartMill fundamental rating of ACCELERANT HOLDINGS-CL A (ARX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ARX.


What is the valuation status for ARX stock?

ChartMill assigns a valuation rating of 3 / 10 to ACCELERANT HOLDINGS-CL A (ARX). This can be considered as Overvalued.


What is the profitability of ARX stock?

ACCELERANT HOLDINGS-CL A (ARX) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for ARX stock?

The Price/Earnings (PE) ratio for ACCELERANT HOLDINGS-CL A (ARX) is 78.35 and the Price/Book (PB) ratio is 7.71.


What is the expected EPS growth for ACCELERANT HOLDINGS-CL A (ARX) stock?

The Earnings per Share (EPS) of ACCELERANT HOLDINGS-CL A (ARX) is expected to grow by 490.07% in the next year.